Holdings (Monthly)
Guide ↗
Invesco Dorsey Wright Healthcare Momentum ETF
· Invesco Exchange-Traded Fund Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | N/A | Apr 2025 | 26,750,346 | $26.8M | 22.06% | STIV |
| 2 | Invesco Private Government Fund | N/A | Apr 2025 | 12,272,488 | $12.3M | 10.12% | STIV |
| 3 | Praxis Precision Medicines, Inc. | 74006W207 | Jan 2026 | 20,476 | $6.4M | 5.30% | EC |
| 4 | Guardant Health, Inc. | 40131M109 | Apr 2025 | 47,375 | $5.4M | 4.45% | EC |
| 5 | Roivant Sciences Ltd. | G76279101 | Jan 2026 | 237,985 | $5.1M | 4.24% | EC |
| 6 | Terns Pharmaceuticals, Inc. | 880881107 | Jan 2026 | 146,784 | $5.1M | 4.19% | EC |
| 7 | Arrowhead Pharmaceuticals, Inc. | 04280A100 | Jan 2026 | 73,173 | $5.1M | 4.18% | EC |
| 8 | Natera, Inc. | 632307104 | Jan 2026 | 18,625 | $4.3M | 3.55% | EC |
| 9 | Revolution Medicines, Inc. | 76155X100 | Jan 2026 | 41,373 | $4.0M | 3.31% | EC |
| 10 | Tenet Healthcare Corp. | 88033G407 | Jan 2026 | 19,008 | $3.6M | 2.97% | EC |
| 11 | Axsome Therapeutics, Inc. | 05464T104 | Apr 2025 | 19,077 | $3.5M | 2.90% | EC |
| 12 | HCA Healthcare, Inc. | 40412C101 | Jan 2026 | 7,064 | $3.4M | 2.84% | EC |
| 13 | Celcuity Inc. | 15102K100 | Jan 2026 | 31,368 | $3.4M | 2.83% | EC |
| 14 | Medpace Holdings, Inc. | 58506Q109 | Jan 2026 | 5,853 | $3.4M | 2.81% | EC |
| 15 | United Therapeutics Corp. | 91307C102 | Jan 2026 | 6,607 | $3.1M | 2.56% | EC |
| 16 | BridgeBio Pharma, Inc. | 10806X102 | Apr 2025 | 39,428 | $3.0M | 2.51% | EC |
| 17 | Madrigal Pharmaceuticals, Inc. | 558868105 | Apr 2025 | 5,820 | $2.8M | 2.35% | EC |
| 18 | Cogent Biosciences, Inc. | 19240Q201 | Jan 2026 | 76,829 | $2.8M | 2.27% | EC |
| 19 | Travere Therapeutics, Inc. | 89422G107 | Jan 2026 | 80,167 | $2.5M | 2.06% | EC |
| 20 | Protagonist Therapeutics, Inc. | 74366E102 | Apr 2025 | 28,303 | $2.3M | 1.91% | EC |
| 21 | Ensign Group, Inc. (The) | 29358P101 | Jan 2026 | 13,319 | $2.3M | 1.89% | EC |
| 22 | BrightSpring Health Services, Inc. | 10950A106 | Jan 2026 | 58,168 | $2.3M | 1.88% | EC |
| 23 | Stoke Therapeutics, Inc. | 86150R107 | Jan 2026 | 73,472 | $2.2M | 1.84% | EC |
| 24 | Alignment Healthcare, Inc. | 01625V104 | Apr 2025 | 94,994 | $2.1M | 1.76% | EC |
| 25 | Harrow, Inc. | 415858109 | Jan 2026 | 48,921 | $2.0M | 1.65% | EC |
| 26 | PACS Group, Inc. | 69380Q107 | Jan 2026 | 57,608 | $1.9M | 1.60% | EC |
| 27 | Immunome, Inc. | 45257U108 | Jan 2026 | 75,314 | $1.9M | 1.53% | EC |
| 28 | Mirum Pharmaceuticals, Inc. | 604749101 | Jan 2026 | 17,506 | $1.8M | 1.49% | EC |
| 29 | Taysha Gene Therapies Inc. | 877619106 | Jan 2026 | 367,229 | $1.7M | 1.37% | EC |
| 30 | Arcutis Biotherapeutics, Inc. | 03969K108 | Apr 2025 | 64,211 | $1.6M | 1.34% | EC |
| 31 | PTC Therapeutics, Inc. | 69366J200 | Apr 2025 | 21,303 | $1.6M | 1.33% | EC |
| 32 | RAPT Therapeutics, Inc. | 75382E208 | Jan 2026 | 27,749 | $1.6M | 1.32% | EC |
| 33 | Ligand Pharmaceuticals Inc. | 53220K504 | Jan 2026 | 7,514 | $1.4M | 1.19% | EC |
| 34 | Nuvation Bio Inc. | 67080N101 | Jan 2026 | 270,074 | $1.4M | 1.17% | EC |
| 35 | IDEAYA Biosciences, Inc. | 45166A102 | Jan 2026 | 43,358 | $1.4M | 1.15% | EC |
| 36 | Alphatec Holdings, Inc. | 02081G201 | Jan 2026 | 93,325 | $1.4M | 1.14% | EC |
| 37 | Tarsus Pharmaceuticals, Inc. | 87650L103 | Jan 2026 | 21,290 | $1.4M | 1.13% | EC |
| 38 | Kymera Therapeutics, Inc. | 501575104 | Jan 2026 | 18,557 | $1.3M | 1.11% | EC |
| 39 | Amneal Pharmaceuticals, Inc. | 03168L105 | Apr 2025 | 95,448 | $1.3M | 1.08% | EC |
| 40 | Axogen, Inc. | 05463X106 | Apr 2025 | 36,410 | $1.3M | 1.05% | EC |
| 41 | Precigen, Inc. | 74017N105 | Jan 2026 | 254,373 | $1.1M | 0.94% | EC |
| 42 | Kodiak Sciences Inc. | 50015M109 | Jan 2026 | 49,083 | $1.1M | 0.92% | EC |
| 43 | Monte Rosa Therapeutics, Inc. | 61225M102 | Jan 2026 | 51,721 | $1.1M | 0.88% | EC |
| 44 | Palvella Therapeutics, Inc. | 697947109 | Jan 2026 | 13,210 | $1.0M | 0.84% | EC |
| 45 | Sionna Therapeutics, Inc. | 829401108 | Jan 2026 | 23,894 | $1.0M | 0.83% | EC |
| 46 | Maze Therapeutics, Inc. | 578784100 | Jan 2026 | 23,056 | $1.0M | 0.83% | EC |
| 47 | Replimune Group, Inc. | 76029N106 | Jan 2026 | 142,365 | $1.0M | 0.83% | EC |
| 48 | Trevi Therapeutics, Inc. | 89532M101 | Apr 2025 | 95,081 | $995K | 0.82% | EC |
| 49 | Upstream Bio, Inc. | 91678A107 | Jan 2026 | 31,208 | $970K | 0.80% | EC |
| 50 | Oruka Therapeutics, Inc. | 687604108 | Jan 2026 | 28,102 | $962K | 0.79% | EC |
| 51 | Annexon, Inc. | 03589W102 | Jan 2026 | 149,595 | $933K | 0.77% | EC |
| 52 | Phathom Pharmaceuticals, Inc. | 71722W107 | Jan 2026 | 64,506 | $882K | 0.73% | EC |
| 53 | AnaptysBio, Inc. | 032724106 | Jan 2026 | 17,433 | $826K | 0.68% | EC |
| 54 | Zymeworks Inc. | 98985Y108 | Jan 2026 | 36,225 | $816K | 0.67% | EC |
| 55 | Fortrea Holdings Inc. | 34965K107 | Jan 2026 | 46,232 | $777K | 0.64% | EC |
| 56 | Artivion, Inc. | 228903100 | Jan 2026 | 18,790 | $766K | 0.63% | EC |
| 57 | Relay Therapeutics, Inc. | 75943R102 | Jan 2026 | 99,689 | $764K | 0.63% | EC |
| 58 | Lexeo Therapeutics, Inc. | 52886X107 | Jan 2026 | 100,460 | $744K | 0.61% | EC |
| 59 | EyePoint, Inc. | 30233G209 | Jan 2026 | 45,221 | $611K | 0.50% | EC |
| 60 | Zenas Biopharma, Inc. | 98937L105 | Jan 2026 | 29,559 | $543K | 0.45% | EC |
| 61 | Invesco Government & Agency Portfolio | 825252885 | Apr 2025 | 162,791 | $163K | 0.13% | STIV |